Find a study location

This information is intended for U.S. audiences only.

Black women And HIV Prevention

Black women pursue HIV prevention as part of their sexual health for several reasons.1

Power, circumstances and control
HIV prevention can increase women’s control over their own bodies and health, particularly in the face of inequality and unpredictable situations.

Intimacy and desire
HIV prevention helps women enjoy sex more by reducing the worry of being exposed to HIV.

Self-care
HIV prevention is an expression of self-love and self-worth, by taking care of their overall health and well-being.

Explore more reasons why Black women choose HIV prevention here.

PrEP is a pill or injection to help keep you HIV-NEGATIVE

PrEP is short for pre-exposure prophylaxis. PrEP has been shown to be a safe and effective method for preventing HIV from sexual contact. However, there can be persistent disparities with women accessing PrEP and the delivery of PrEP care to Black women.

DIVERSITY MATTERS

IN HIV PREVENTION RESEARCH

HIV has a disproportionate impact on Black women. 1, 2, 3

Black women make up less than

15%

of the female population yet they comprise

55%

of new HIV diagnoses among cis women and

46%

of new diagnoses among trans women

Each year, more than 4,100 Black women receive an HIV diagnosis and are often shocked when this occurs

Only 10% of women who could benefit from PrEP are actually prescribed it

Historically, communities of color have been left out of health research4

In the last 2 decades, only:

10%

of US-based clinical trials have included Black/African American patient populations

TIME FOR A CHANGE

To disrupt the impact of HIV among Black women, it is important to understand their experiences, views, perceptions and reasons for PrEP care.

THE EBONI STUDY IS FOR BLACK WOMEN WHO ARE INTERESTED IN PREVENTING HIV BY USING PrEP

THE EBONI STUDY

This study is for women who have already made the decision with their provider to use (but have not yet started) APRETUDE (Cabotegravir LA for PrEP).5  We want to help providers figure out best practices for using APRETUDE in their clinic and identify ways in which to support women receiving APRETUDE.

APRETUDE is the first long-acting injectable form of PrEP.

JOINING THE STUDY WILL HELP US UNDERSTAND:

Your interactions
with providers

How easy or hard it
is for you to receive
APRETUDE

How APRETUDE
works for you

If certain tools and information
about APRETUDE can help
you understand, start, and
maintain PrEP

How your provider
delivers APRETUDE
in clinic

EBONI is a Phase 4 Implementation Research Clinical Trial

Phase 4 studies happen after a drug is approved by the FDA. This study is not intended to further test that the drug works and is safe. EBONI aims to enroll 100% Black women, including 20-30% trans women.

You are eligible to participate in eboni if you are:

18 years or older

Identify as Black or African American

Identify as a cisgender or transgender woman

HOW THE EBONI STUDY WORKS

We understand joining a study is a big decision. We want you to understand the steps along the way to help you make an informed decision.

Talk with a participating provider about your sexual health

Complete consent to be part of the study if APRETUDE is the right choice for you

  • Your care with APRETUDE would not change based on your decision to join the study
  • Your provider will perform tests based on your medical care/PrEP needs
  • No additional tests are required for this study

Answer health surveys

  • You answer surveys at your convenience using your computer, tablet or phone
  • Your provider will tell you when to take the surveys
  • You will be compensated for your time answering surveys

Participate in interviews

  • You may or may not be selected to participate in interviews. Interviews are all virtual
  • Your provider will tell you if you were selected
  • You will be compensated for your time participating in interviews

Use study supports if you need them

  • Your provider will tell you about some of the additional supports you may receive being a part of the study
  • You will have the opportunity to give us your feedback on surveys and interviews

FREQUENTLY ASKED QUESTIONS

Is APRETUDE an experimental drug?

No. APRETUDE is approved by the FDA.

What will happen to the information provided in the study?

We will use the information to better understand what works for women who are using APRETUDE and share this information with providers to help improve care in the future.

Who is running the study?

ViiV Healthcare (part of GSK) is a global HIV company that develops drugs for the prevention and treatment of HIV. ViiV/GSK is the sponsor of this study. Syneos Health is a contract research organization that provides services to companies like ViiV/GSK to manage research studies.

What will participants do during the study?

You will be asked to answer 3 surveys and some participants will have 2 interviews over the 12 months. Surveys and interviews will ask how you are feeling and most importantly, your experience with APRETUDE. Interviews will be virtual. You will be compensated for the survey and interview time.

How will I obtain APRETUDE?

You would follow the usual process with your insurance provider to obtain coverage for APRETUDE.

FIND A STUDY LOCATION NEAR ME

Choose your location to find a study location nearest you

Your Location

19 Locations

Clinic NameClinic PhoneDistance

AHF Manhattan Midtown HCC

352 7th Ave, Suite 1205, New York, NY 10001

https://ahf.org/

212-627-7560, ext 51454

—

AvitaCare Atlanta

2140 Peachtree Rd #232, Atlanta, GA 30309

www.avitacareatlanta.com

404-231-4431

—

CAN Community Health (Norfolk, VA)

1001 Monticello Ave. Suite 100, Norfolk, VA 23510

https://www.cancommunityhealth.org/norfolk-va/

757-346-5770

—

Care Resource Community Health Centers Inc.

3510 Biscayne Blvd, Miami, FL 33137

https://careresource.org/

305-576-1234

—

Emory University at Grady Hospital

80 Jesse Hill Jr Drive SE, Atlanta, GA 30303

https://www.gradyhealth.org/get-prep-hiv-prevention-pill/

404-616-7737

—

Faebris Medical & Community Education

2193 Cascade Road SW, Atlanta, GA 30311

https://www.faebris.com/

844-884-9691

—

Legacy Community Health

120 Westheimer Road, Suite F, Houston, TX 77006

https://www.wellnessbarbylegacy.org/

713-814-3730

—

Madewell Obstetrics and Gynecology

2509 Thomas Ave, Dallas, TX 75201

https://www.madewellobgyn.com/

214-421-4800

—

Mazzoni Center

1348 Bainbridge Street, 2nd Floor, Phildelphia, PA 19147

https://www.mazzonicenter.org/

215-563-0658

—

MedStar Washington Hospital Center

110 Irving St NW, East Building 5108, Washington, DC 20010

https://www.medstarhealth.org/innovation-and-research/medstar-health-research-institute

202-877-7473

—

Midway Specialty Care Center

5224 E. Fowler Ave, Temple Terrace, FL 33617-2147

https://midwaycare.org/locations/temple-terrace/

813-902-8600

—

Mount Sinai OB/GYN Ambulatory Practice

1176 5th Ave, Floor E, New York, NY 10029

https://www.mountsinai.org/locations/mount-sinai/care/ambulatory-care/obgyn

212-659-8557 or 212-824-7714

—

Newlands Health

9625 Frankford Avenue, Philadelphia, PA 19114

https://newlandsphilly.org

215-941-1236

—

Next Innovative Clinical Research

12401 S Post Oak, Houston, TX 77045

https://www.nexticr.com/

1-708-955-7856

—

Southwest Community Health Center

46 Albion Street, Bridgeport, CT 06605

https://swchc.org

203-503-3000

—

Spirit Health

1331 Union Ave. 1240 Memphis, TN 38104

https://www.spirithealthmedical.com/

901-522-5341

—

Washington Health Institute

1140 Varnum St NE, Suite 203, Washington, DC 20017

https://dc-whi.org/

202-525-5175

—

Wayne State University

400 Mack, Suite 1E, Detroit, MI 48201

https://www.wsup313.com/

734-531-8877 or 313-702-0727

—

Whitman-Walker Institute, Inc

1525 14th St NW, Washington, DC, 20005
or
1201 Sycamore Dr SE, Washington, DC 20032

https://whitmanwalkerimpact.org/institute/

202-991-6885

—

This website is intended to provide EBONI study information only.

Viiv Healthcare
Five Moore Drive
Research Triangle Park
North Carolina USA
27709-3398

Tel: +1 877 ViiVUSA (+1 877 844 8872)

Terms of use

Cookie policy

Privacy policy

Copyright notice: ©2023 ViiV Healthcare group of companies. All rights reserved. ViiV Healthcare UK Limited. Registered in England and Wales No. 06990358
Registered Office. Registered office: ViiV Healthcare, Five Moore Drive, Research Triangle Park, North Carolina USA, 27709-3398, Tel: +1 877 ViiVUSA (+1 877 844 8872)

X

ViiV Healthcare Privacy Notice

1. Introduction

Your trust is important to us. We are committed to treating your personal information with care and integrity. ViiV Healthcare UK Limited (“ViiV”) is the controller of your personal information. All personal information collected is held by Syneos Health, LLC on behalf of ViiV. This Notice explains how ViiV through Syneos Health, LLC. acting on ViiV’s behalf ("we", "us" and "our") collect, use, store, and disclose the personal information relating to you as part of your application to the EBONI Screening Website.

2. The personal information that we process may include:

  • your basic information – zip code which will not be stored upon finding a study location.

3. We will not collect your personal information through the EBONI Screening Website

4. We will not use your personal information for any purposes.

5. On what basis do we use your personal information?

We use your personal information on the following basis:

  • for legitimate business purposes – using personal information helps us to operate, plan and improve our business activities. It also helps your Physician to determine whether you are eligible for a ViiV sponsored clinical study.
  • to comply with legal, regulatory and other compliance obligations – compliance with laws, regulations, rules, codes and guidance is important to us, and we would want to be able to comply with these.
  • because you have given your consent - we will ask for your consent to allow us to use your personal information for one or more purposes. See “Your rights” for information about the rights that you may have if we process your information on the basis of your consent.

6. How long will we keep your personal information?

No personal information will be stored.

7. With whom do we share your personal information?

No personal information will be collected nor shared.

8. Transfers of your personal information outside of your home country

Your data will not be transferred outside of the United States

9. Protecting your personal information

We will use a variety of security measures and technologies to help protect your personal information from unauthorised access, use, disclosure, alteration or destruction, consistent with applicable privacy and data security laws. For example, when we retain a third-party service provider, that provider will be carefully selected in accordance with our policies and procedures, and which commits the third-party service provider to use appropriate safeguards in relation to the handling of your personal information (including in relation to maintaining confidentiality of your personal information and implementing appropriate technical and organisational security measures).

No personal data will be stored.

10. Your rights

Please contact Syneos Health, LLC. if you wish to learn more about individual rights you have to your data

11. Contact Us

If you have questions or requests regarding this Privacy Notice, or if you would like to exercise your rights, please contact support@bocodigital.com and they will facilitate contact with us.

12. Data controller and Data Protection Officer

ViiV Healthcare UK Limited is the controller of your personal information. You can contact ViiV’s EU Data Protection Officer by emailing EU.DPO@gsk.com. Please note that ViiV’s EU Data Protection Officer is also GlaxoSmithKline’s EU Data Protection Officer.